Drug Repairs DNA in Early Alzheimer's, Cleared Safety Trials

A drug that's already passed human safety trials can repair DNA damage and reduce inflammation in the earliest stages of Alzheimer's disease.

The breakthrough could fast-track a treatment that tackles multiple causes of the disease at once.